MedPath

Safety and Feasibility of Arrhythmia Ablation Using the Amigo Remote Robotic System as Compared With Manual Ablation

Phase 4
Conditions
Arrhythmias
Interventions
Device: Amigo
Device: Manual ablation
Registration Number
NCT01834872
Lead Sponsor
Instituto de Investigación Sanitaria Gregorio Marañón
Brief Summary

The aim of this prospective observational study is to evaluate the performance of Amigo RCS in ablation procedures for most common arrhythmias as compared to a conventional manual approach.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Patients referred to our electrophysiology laboratory to treat any type of arrhythmia with catheter ablation
Exclusion Criteria
  • NA

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
AmigoAmigoAblation completed with Amigo
ManualManual ablationAblation completed with manual catheter
Primary Outcome Measures
NameTimeMethod
Ablation Success1 year

Global efficacy:

Recurrence rate Re-do procedures Proportion of patients under anti arrhythmic treatment

Safety Endpoint1 Year

Any complications that could be attributed to the procedure during follow-up.

Secondary Outcome Measures
NameTimeMethod
Acute Ablation SuccessDuring Procedure

Accessory pathway: Anterograde and retrograde conduction block through the accessory Pathway Atrial fibrillation: % patients with all PV disconnected circumferential ablation with electrical disconnection of all pulmonary veins Common-type atrial flutter: Bidirectional cavotricuspid isthmus block AVNRT/Ventricular tachycardia/other atrial arrhythmias: Arrhythmia termination / absence o induction

Acute Safety EndpointDuring Procedure

Procedure complications: Any complication during the electrophysiological procedure and 1 week post ablation that could be attributed to the procedure: Vascular complication, pericardial effusion/cardiac tamponade, heart failure, others.

The number of adverse events will be collected.

Trial Locations

Locations (1)

Hospital General Universitario Gregorio Marañón

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath